NYSE:TDOCTeladoc Health Stock Price, Forecast & News

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TDOC stock has increased by 65.9% and is now trading at $227.88. View which stocks have been most impacted by Coronavirus.

25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 13 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Teladoc Health.

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Teladoc Health.

Teladoc Health Inc (NYSE:TDOC) released its earnings results on Wednesday, April, 29th. The health services provider reported ($0.40) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.35) by $0.05. The health services provider had revenue of $180.80 million for the quarter, compared to analysts' expectations of $180.64 million. Teladoc Health had a negative net margin of 16.24% and a negative return on equity of 10.60%. Teladoc Health's quarterly revenue was up 40.6% on a year-over-year basis. During the same period in the previous year, the company posted ($0.43) earnings per share. View Teladoc Health's earnings history.

Teladoc Health updated its second quarter 2020 After-Hours earnings guidance on Wednesday, April, 29th. The company provided EPS guidance of -0.28--0.23 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.3. The company issued revenue guidance of $215-225 million, compared to the consensus revenue estimate of $182.26 million.

25 brokers have issued 12-month target prices for Teladoc Health's shares. Their forecasts range from $80.00 to $250.00. On average, they anticipate Teladoc Health's share price to reach $166.13 in the next year. This suggests that the stock has a possible downside of 27.1%. View analysts' price targets for Teladoc Health.

News articles about TDOC stock have been trending negative this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Teladoc Health earned a news impact score of -2.1 on InfoTrie's scale. They also gave media stories about the health services provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Teladoc Health.

Some companies that are related to Teladoc Health include Anthem (ANTM), Zoetis (ZTS), Bayer (BAYN), Takeda Pharmaceutical (TAK), Illumina (ILMN), Humana (HUM), Boston Scientific (BSX), Biogen (BIIB), Baxter International (BAX), Edwards Lifesciences (EW), LONZA GRP AG/ADR (LZAGY), Siemens Healthineers (SHL), DexCom (DXCM), Centene (CNC) and RESMED/IDR UNRESTR (RMD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), Shopify (SHOP), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS), Trade Desk (TTD), Square (SQ), salesforce.com (CRM) and Paypal (PYPL).

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Teladoc Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.84%), Envestnet Asset Management Inc. (0.13%), Spence Asset Management (0.05%), Carnegie Capital Asset Management LLC (0.04%), Legacy Capital Partners Inc. (0.01%) and DNB Asset Management AS (0.01%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete and William H Frist. View institutional ownership trends for Teladoc Health.

TDOC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Spence Asset Management, Legacy Capital Partners Inc., Carnegie Capital Asset Management LLC, and Arden Trust Co. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, David L Shedlarz, Gabriel R Cappucci, Jason N Gorevic, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen, Stephany Verstraete, and William H Frist. View insider buying and selling activity for Teladoc Health.

TDOC stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Envestnet Asset Management Inc., IBM Retirement Fund, and Livforsakringsbolaget Skandia Omsesidigt. View insider buying and selling activity for Teladoc Health.

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TDOC stock can currently be purchased for approximately $227.88.

Teladoc Health has a market capitalization of $16.97 billion and generates $553.31 million in revenue each year. The health services provider earns $-98,860,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Teladoc Health employs 2,400 workers across the globe.

The official website for Teladoc Health is www.teladoc.com.

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]